These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28110473)

  • 1. How Presentation of Drug Detection Results Changed Reports of Product Adherence in South Africa, Uganda and Zimbabwe.
    Musara P; Montgomery ET; Mgodi NM; Woeber K; Akello CA; Hartmann M; Cheng H; Levy L; Katz A; Grossman CI; Chirenje ZM; van der Straten A; Mensch B;
    AIDS Behav; 2018 Mar; 22(3):877-886. PubMed ID: 28110473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misreporting of Product Adherence in the MTN-003/VOICE Trial for HIV Prevention in Africa: Participants' Explanations for Dishonesty.
    Montgomery ET; Mensch B; Musara P; Hartmann M; Woeber K; Etima J; van der Straten A
    AIDS Behav; 2017 Feb; 21(2):481-491. PubMed ID: 27858268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?
    Mensch BS; Brown ER; Liu K; Marrazzo J; Chirenje ZM; Gomez K; Piper J; Patterson K; van der Straten A
    AIDS Behav; 2016 Nov; 20(11):2654-2661. PubMed ID: 26906023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
    Luecke EH; Cheng H; Woeber K; Nakyanzi T; Mudekunye-Mahaka IC; van der Straten A;
    J Int AIDS Soc; 2016; 19(1):20875. PubMed ID: 27247202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe.
    Duby Z; Katz AWK; Browne EN; Mutero P; Etima J; Zimba CC; Woeber K; Atujuna M; Reddy K; van der Straten A;
    AIDS Behav; 2020 Feb; 24(2):617-628. PubMed ID: 31030301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
    Govender EM; Mansoor LE; Abdool Karim Q
    AIDS Care; 2017 Jun; 29(6):734-740. PubMed ID: 27799005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disclosure of pharmacokinetic drug results to understand nonadherence.
    van der Straten A; Montgomery ET; Musara P; Etima J; Naidoo S; Laborde N; Hartmann M; Levy L; Bennie T; Cheng H; Piper J; Grossman CI; Marrazzo J; Mensch B;
    AIDS; 2015 Oct; 29(16):2161-71. PubMed ID: 26544581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE.
    Mensch BS; Richardson BA; Husnik M; Brown ER; Kiweewa FM; Mayo AJ; Baeten JM; Palanee-Phillips T; van der Straten A;
    AIDS Behav; 2019 Feb; 23(2):504-512. PubMed ID: 30218318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda.
    Stoner MCD; Hawley I; Mathebula F; Horne E; Etima J; Kemigisha D; Mutero P; Dandadzi A; Seyama L; Fabiano Z; Scheckter R; Noguchi L; Owor M; Balkus JE; Montgomery ET
    AIDS Behav; 2023 Dec; 27(12):4114-4123. PubMed ID: 37432541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence.
    Katz AWK; Mensch BS; Woeber K; Musara P; Etima J; van der Straten A
    BMC Womens Health; 2019 Jan; 19(1):18. PubMed ID: 30683103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sharing of Investigational Drug Among Participants in the Voice Trial.
    Moodley J; Naidoo S; Moodley J; Ramjee G
    AIDS Behav; 2016 Nov; 20(11):2709-2714. PubMed ID: 27146827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR; Wallace M; Bekker LG; Roux S; Atujuna M; Sebastian E; Dye BJ; Elharrar V; Grant RM
    AIDS Behav; 2017 May; 21(5):1361-1375. PubMed ID: 27317411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative Perceptions of Dapivirine VR Adherence and Drug Level Feedback Following an Open-Label Extension Trial.
    Naidoo K; Mansoor LE; Katz AWK; Garcia M; Kemigisha D; Morar NS; Zimba CC; Chitukuta M; Reddy K; Soto-Torres L; Naidoo S; Montgomery ET
    J Acquir Immune Defic Syndr; 2021 Apr; 86(4):e90-e96. PubMed ID: 33278181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of drug detection monitoring among participants in an open-label pre-exposure prophylaxis study.
    Koester KA; Liu A; Eden C; Amico KR; McMahan V; Goicochea P; Hosek S; Mayer KH; Grant RM
    AIDS Care; 2015; 27(10):1199-204. PubMed ID: 26001026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted combination prevention to support female sex workers in Zimbabwe accessing and adhering to antiretrovirals for treatment and prevention of HIV (SAPPH-IRe): a cluster-randomised trial.
    Cowan FM; Davey C; Fearon E; Mushati P; Dirawo J; Chabata S; Cambiano V; Napierala S; Hanisch D; Wong-Gruenwald R; Masuka N; Mabugo T; Hatzold K; Mugurungi O; Busza J; Phillips A; Hargreaves JR
    Lancet HIV; 2018 Aug; 5(8):e417-e426. PubMed ID: 30030134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
    AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Condoms, Lubricants and Rectal Cleansing: Practices Associated with Heterosexual Penile-Anal Intercourse Amongst Participants in an HIV Prevention Trial in South Africa, Uganda and Zimbabwe.
    Duby Z; Hartmann M; Montgomery ET; Colvin CJ; Mensch B; van der Straten A
    AIDS Behav; 2016 Apr; 20(4):754-62. PubMed ID: 26126586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.